Tag: NASDAQ:GILD

BioTech

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares declined 1.14% to $8.65. The company on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -2.87% in last session and finished the day at $8.13. Traded volume was 13.50million shares in the last session and the average volume … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Jason Knox
BioTech

Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Officials with Zogenix Inc. (NASDAQ:ZGNX), the San Diego-based maker of Zohydro, did not return a message seeking comment about the drug. The company is marketing the drug as the first extended-release hydrocodone pain reliever without acetaminophen, which can cause liver failure if taken in excess. Zogenix, Inc. (NASDAQ:ZGNX) stock performance was -14.18% in last session and finished the day at $3.84. Traded volume was 9.38million … Continue reading Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Kristen Barton
FB Nasdaq FB Facebook
Analyst Actions

Gilead (NASDAQ:GILD) Altripla Recall a Non-Issue According to Deutsche Bank

Deutsche Bank said Gilead(NASDAQ:GILD)’s Atripla recall is not an issue. The firm said Gilead proactively issued the recall following a typical quality check that found small particles and notes the company has multiple manufacturers for Atripla. Management said it was a minor issue and that Atripla supply is more than enough. Shares are Buy rated with a $132 price target. In a note issued by … Continue reading Gilead (NASDAQ:GILD) Altripla Recall a Non-Issue According to Deutsche Bank

John Meady
BioTech

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -3.34% in last session and finished the day at $8.69. Traded volume was 1,200.00 shares in the last session and the average volume of the stock remained 26.48 million shares. The beta of the stock remained 1.64. Ariad Pharmaceuticals, Inc. … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Kevin Long
Diversified Tech

Ever Green Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Delta Air Lines (NYSE:DAL), Central Garden & Pet Company (NASDAQ:CENT), Safeway (NYSE:SWY), Nomura (NYSE:NMR)

Strides Arcolab, announced that it has entered into a licensing agreement with Gilead Sciences Inc. (NASDAQ:GILD)under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is 5.92%. On last trading … Continue reading Ever Green Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Delta Air Lines (NYSE:DAL), Central Garden & Pet Company (NASDAQ:CENT), Safeway (NYSE:SWY), Nomura (NYSE:NMR)

Jayne Crisman
Finance

Ever Green Stocks: The Charles Schwab Corporation (NYSE:SCHW), Gilead Sciences Inc. (NASDAQ:GILD), NextEra Energy Partners, LP (NYSE:NEP), Teleflex (NYSE:TFX), Fuel-Tech (NASDAQ:FTEK)

The PGA Tour and The Charles Schwab Corporation (NYSE:SCHW) have reached an agreement to extend the sponsorship of the Champions Tour’s season-long points race and season-ending tournament for 20 years — the longest marketing agreement the Tour has ever signed with a sponsor. The Charles Schwab Corporation (NYSE:SCHW) belongs to Financial sector. Its net profit margin is 20.30% and weekly performance is -5.04%. On last … Continue reading Ever Green Stocks: The Charles Schwab Corporation (NYSE:SCHW), Gilead Sciences Inc. (NASDAQ:GILD), NextEra Energy Partners, LP (NYSE:NEP), Teleflex (NYSE:TFX), Fuel-Tech (NASDAQ:FTEK)

Kevin Long